corticosteroids

Managing viral eye infection: What clinicians should knowThough much research is happening in the diagnosis and treatment of viral eye infections, much of it might not be readily apparent to clinicians, explains Todd P. Margolis, MD, PhD.
Pruritic vesicles erupt on a boy’s legsA healthy 12-year-old boy with eczema shows up at the office with an incredibly itchy rash on his legs that has exploded over the last 48 hours. He has a history of dry skin to which his mother regularly applies various moisturizers, including calendula oil.
Selecting topical regimens for cataract patients
Selecting topical regimens for cataract patientsEyecare practitioners who deal with patients in the perioperative period are well aware of the need for topical therapy. In most cases, a combination of a steroid, a nonsteroidal anti-inflammatory drug (NSAID), and an antibiotic will be used for a few days before the day of surgery and then for a period afterward.
Clinical pearls for treating uveitisUveitis presents particular problems for ophthalmologists. Inflammation inside the eye can occur from so many causes that the diagnosis often requires painstaking, time-consuming investigation. As researchers have learned more about the disease, the possible etiologies and treatments have multiplied.
Small-particle inhaled corticosteroids: Paradigm shift in asthma treatmentNew research suggests that the use of small-particle inhaled corticosteroids as a first-line or step-up therapy for uncontrollable asthma in children would be more helpful in clearing symptoms and preventing exacerbations than traditional treatment approaches such as large-particle inhaled corticosteroids with or without the addition of long-acting beta 2 agonists.
Exploring balance of controlling inflammation, IOP in uveitisClinicians need to weigh such factors as inflammation and IOP in determining when steroid therapy is beneficial in uveitic glaucoma.
Latest concepts in steroid therapy for diabetic macular oedemaSteroids are an important second-line treatment for the treatment of diabetic macular oedema. While side effects remain a concern, modern formulations of intravitreal steroid allow the treatment to be tailored to the individual patient.
Study: Fluocinolone acetonide 0.2 µg/day reduced DR progressionTreatment with fluocinolone acetonide 0.2 µg/day significantly reduced progression to proliferative diabetic retinopathy (PDR) in patients who were part of the FAME trials1,2 and had visual acuity loss due to diabetic macular edema (DME), according to Charles C. Wykoff, MD, PhD.
New rheumatoid arthritis therapies are comingFour new drugs and a biosimilar should be on your radar.
Inhaled corticosteroids may stunt growth in infants with asthmaLead researcher says next step is to evaluate effects in older children for longer period of time.